Concepedia
Statistics
Publications
16
Citations
718
H-Index
15
Active since
2013
Affiliations
Infectious Disease Research Institute(Current)
Eli Lilly (United States)
University of Notre Dame
Jubilant Life Sciences (India)
Texas A&M University
Torey Alling is an author at Infectious Disease Research Institute specializing in pharmacology, medicine, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryDrug ResistanceBiochemistryTuberculosisMicrobiologyNatural SciencesMedicinal ChemistryAntimicrobial Resistance
Publications per year
2013–2018
A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
Juliane Ollinger, Mai A. Bailey, Garrett C. Moraski et al. · PLoS ONE · 2013 · 175 citations · Full text
Antimicrobial Chemotherapy, Bacterium Mycobacterium Tuberculosis, Drug Resistance +21
Advancement of Imidazo[1,2-<i>a</i>]pyridines with Improved Pharmacokinetics and nM Activity vs. <i>Mycobacterium tuberculosis</i>
Garrett C. Moraski, Lowell D. Markley, Jeffrey W. Cramer et al. · ACS Medicinal Chemistry Letters · 2013 · 111 citations · Full text
Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents
Edward A. Kesicki, Mai A. Bailey, Yulia Ovechkina et al. · PLoS ONE · 2016 · 57 citations · Full text
Anti-tubercular Agents, Bioorganic Chemistry, Pharmacotherapy +17
Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels
Theresa O’Malley, Torey Alling, Julie V. Early et al. · Antimicrobial Agents and Chemotherapy · 2018 · 54 citations · Full text
Bioorganic & Medicinal Chemistry 22 (2014) 6965–6979
J. Oluoch Odingo, Theresa O’Malley, Edward A. Kesicki et al. · 2014 · 52 citations
Medicinal Chemistry 22, Medicinal Chemistry, Bioorganic Chemistry +8
1–5 of 16